Literature DB >> 33296437

Transmissibility of COVID-19 depends on the viral load around onset in adult and symptomatic patients.

Hitoshi Kawasuji1, Yusuke Takegoshi1, Makito Kaneda1, Akitoshi Ueno1, Yuki Miyajima1, Koyomi Kawago1, Yasutaka Fukui1, Yoshihiro Yoshida2, Miyuki Kimura2, Hiroshi Yamada2, Ippei Sakamaki1, Hideki Tani2, Yoshitomo Morinaga2, Yoshihiro Yamamoto1.   

Abstract

OBJECTIVE: To investigate the relationship between viral load and secondary transmission in novel coronavirus disease 2019 (COVID-19).
METHODS: Epidemiological and clinical data were obtained from immunocompetent laboratory-confirmed patients with COVID-19 who were admitted to and/or from whom viral loads were measured at Toyama University Hospital. Using a case-control approach, index patients who transmitted the disease to at least one other patient were analysed as "cases" (index patients) compared with patients who were not the cause of secondary transmission (non-index patients, analysed as "controls"). The viral load time courses were assessed between the index and non-index symptomatic patients using non-linear regression employing a standard one-phase decay model.
RESULTS: In total, 28 patients were included in the analysis. Median viral load at the initial sample collection was significantly higher in symptomatic than in asymptomatic patients and in adults than in children. Among symptomatic patients (n = 18), non-linear regression models showed that the estimated viral load at onset was higher in the index than in the non-index patients (median [95% confidence interval]: 6.6 [5.2-8.2] vs. 3.1 [1.5-4.8] log copies/μL, respectively). In adult (symptomatic and asymptomatic) patients (n = 21), median viral load at the initial sample collection was significantly higher in the index than in the non-index patients (p = 0.015, 3.3 vs. 1.8 log copies/μL, respectively).
CONCLUSIONS: High nasopharyngeal viral loads around onset may contribute to secondary transmission of COVID-19. Viral load may help provide a better understanding of why transmission is observed in some instances, but not in others, especially among household contacts.

Entities:  

Year:  2020        PMID: 33296437     DOI: 10.1371/journal.pone.0243597

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  39 in total

1.  The Impact of the Highly Virulent SARS-CoV-2 Gamma Variant on Young Adults in the State of São Paulo: Was It Inevitable?

Authors:  Beny Spira
Journal:  Cureus       Date:  2022-07-01

Review 2.  Nirmatrelvir combined with ritonavir for preventing and treating COVID-19.

Authors:  Stefanie Reis; Maria-Inti Metzendorf; Rebecca Kuehn; Maria Popp; Ildiko Gagyor; Peter Kranke; Patrick Meybohm; Nicole Skoetz; Stephanie Weibel
Journal:  Cochrane Database Syst Rev       Date:  2022-09-20

3.  Clinical Performance of Three Commercial SARS-CoV-2 Rapid Antigen Tests for Community-Dwelling Individuals in a Tropical Setting.

Authors:  Diana Morales-Jadán; Carolina Viteri-Dávila; Bernardo Castro-Rodriguez; Alexander Paolo Vallejo-Janeta; Ismar A Rivera-Olivero; Franklin Perez; Miguel Angel Garcia-Bereguiain
Journal:  Front Cell Infect Microbiol       Date:  2022-07-05       Impact factor: 6.073

4.  Efficacy of the Sentinox Spray in Reducing Viral Load in Mild COVID-19 and Its Virucidal Activity against Other Respiratory Viruses: Results of a Randomized Controlled Trial and an In Vitro Study.

Authors:  Donatella Panatto; Andrea Orsi; Bianca Bruzzone; Valentina Ricucci; Guido Fedele; Giorgio Reiner; Nadia Giarratana; Alexander Domnich; Giancarlo Icardi
Journal:  Viruses       Date:  2022-05-12       Impact factor: 5.818

5.  Possible effects of air temperature on COVID-19 disease severity and transmission rates.

Authors:  Dominique Kang; Clifford Ellgen; Erik Kulstad
Journal:  J Med Virol       Date:  2021-05-03       Impact factor: 20.693

6.  A case of COVID-19 diagnosed with favipiravir-induced drug fever based on a positive drug-induced lymphocyte stimulation test.

Authors:  Yushi Murai; Hitoshi Kawasuji; Yusuke Takegoshi; Makito Kaneda; Kou Kimoto; Akitoshi Ueno; Yuki Miyajima; Koyomi Kawago; Yasutaka Fukui; Chika Ogami; Ippei Sakamaki; Yasuhiro Tsuji; Yoshitomo Morinaga; Yoshihiro Yamamoto
Journal:  Int J Infect Dis       Date:  2021-03-18       Impact factor: 12.074

7.  COVID-19 transmission: a rapid systematic review of current knowledge.

Authors:  Panagiotis Mourmouris; Lazaros Tzelves; Christiana Roidi; Anastasia Fotsali
Journal:  Osong Public Health Res Perspect       Date:  2021-04-29

Review 8.  Antibody-Dependent Enhancement and the Critical Pattern of COVID-19: Possibilities and Considerations.

Authors:  Fatemeh Farshadpour; Reza Taherkhani
Journal:  Med Princ Pract       Date:  2021-04-21       Impact factor: 1.927

9.  Higher Viral Load Drives Infrequent Severe Acute Respiratory Syndrome Coronavirus 2 Transmission Between Asymptomatic Residence Hall Roommates.

Authors:  Kristen K Bjorkman; Tassa K Saldi; Erika Lasda; Leisha Conners Bauer; Jennifer Kovarik; Patrick K Gonzales; Morgan R Fink; Kimngan L Tat; Cole R Hager; Jack C Davis; Christopher D Ozeroff; Gloria R Brisson; Daniel B Larremore; Leslie A Leinwand; Matthew B McQueen; Roy Parker
Journal:  J Infect Dis       Date:  2021-10-28       Impact factor: 5.226

Review 10.  Original Hosts, Clinical Features, Transmission Routes, and Vaccine Development for Coronavirus Disease (COVID-19).

Authors:  Ting Wu; Shuntong Kang; Wenyao Peng; Chenzhe Zuo; Yuhao Zhu; Liangyu Pan; Keyun Fu; Yaxian You; Xinyuan Yang; Xuan Luo; Liping Jiang; Meichun Deng
Journal:  Front Med (Lausanne)       Date:  2021-07-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.